Calcium oxalate is the leading cause of renal stones, yet the medical literature rarely explores the potential systemic effects of this molecule. Oxalates are known to deposit in tissues throughout the body, where they may disrupt cellular function and calcium homeostasis, stimulate immune responses, and increase oxidative stress.

A growing body of observations from online patient communities trialling low-oxalate diets reports a range of health benefits and relief from chronic extra-renal symptoms. These experiences have begun to inform the practice of Functional and Nutritional Medicine internationally, and advice on reducing dietary oxalates is becoming more common among practitioners, although robust published evidence remains limited and further research is needed to guide identification and treatment of systemic oxalosis.

At the Functional Nexus Clinic, available literature and clinical observations have been used to explore oxalates as a potential contributor to complex multi-system illness. Following the incidental discovery that a severely unwell patient with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome had previously unrecognised Primary hyperoxaluria, it became apparent that identifying affected patients was challenging and that some standard dietary advice might inadvertently contribute to oxalate burden in susceptible individuals.

After three years of increased clinical awareness, an audit of the clinic’s active patient database identified 15 patients demonstrating measurable health improvements following a lower-oxalate diet. Responsive conditions included Ehlers-Danlos syndrome, Postural Orthostatic Tachycardia Syndrome, Mast Cell Activation Syndrome, benign positional vertigo, recurrent urinary tract infections, vulval pain, joint pain and granuloma annulare.

Review of this case series raises several unanswered questions and highlights the need for further investigation into the potential role of systemic oxalosis in chronic illness and its implications for future patient care.